LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

Leucine-rich repeat protein

Quick info Annotations Function or PPIs Localization Expansion Sequence features Structure Putative motif mimicry Homologs Download

Quick info

Protein:
Leucine-rich repeat protein
Gene product:
hypothetical protein, conserved
Species:
Leishmania braziliensis
UniProt:
A4H461_LEIBR
TriTrypDb:
LbrM.05.0150 , LBRM2903_050006400
Length:
442

Annotations

LeishMANIAdb annotations

Leucine-rich repeat proteins with a hydrophobic terminal helix. Unlike its distant animal relatives, this cytoplasmic sensor protein might be anchored to the membrane.

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 30
NetGPI no yes: 0, no: 30
Cellular components
Term Name Level Count
GO:0005929 cilium 4 30
GO:0042995 cell projection 2 30
GO:0043226 organelle 2 30
GO:0043227 membrane-bounded organelle 3 30
GO:0110165 cellular anatomical entity 1 31
GO:0120025 plasma membrane bounded cell projection 3 30
GO:0016020 membrane 2 2
GO:0005737 cytoplasm 2 1
GO:0005930 axoneme 2 1

Expansion

Sequence features

A4H461
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: A4H461

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_NRD_NRD_1 378 380 PF00675 0.404
CLV_NRD_NRD_1 6 8 PF00675 0.648
CLV_PCSK_KEX2_1 29 31 PF00082 0.295
CLV_PCSK_KEX2_1 378 380 PF00082 0.425
CLV_PCSK_KEX2_1 6 8 PF00082 0.648
CLV_PCSK_PC1ET2_1 29 31 PF00082 0.255
CLV_PCSK_SKI1_1 130 134 PF00082 0.380
CLV_PCSK_SKI1_1 158 162 PF00082 0.334
CLV_PCSK_SKI1_1 265 269 PF00082 0.500
CLV_PCSK_SKI1_1 32 36 PF00082 0.345
CLV_PCSK_SKI1_1 361 365 PF00082 0.396
CLV_PCSK_SKI1_1 379 383 PF00082 0.499
CLV_PCSK_SKI1_1 50 54 PF00082 0.307
DEG_SPOP_SBC_1 239 243 PF00917 0.389
DOC_CYCLIN_RxL_1 276 285 PF00134 0.290
DOC_MAPK_gen_1 378 385 PF00069 0.481
DOC_MAPK_MEF2A_6 378 385 PF00069 0.517
DOC_PP1_RVXF_1 404 411 PF00149 0.388
DOC_USP7_MATH_1 110 114 PF00917 0.274
DOC_USP7_MATH_1 240 244 PF00917 0.315
DOC_USP7_MATH_1 402 406 PF00917 0.610
DOC_USP7_UBL2_3 436 440 PF12436 0.518
DOC_WW_Pin1_4 117 122 PF00397 0.457
DOC_WW_Pin1_4 395 400 PF00397 0.335
LIG_14-3-3_CanoR_1 130 136 PF00244 0.416
LIG_14-3-3_CanoR_1 224 230 PF00244 0.519
LIG_14-3-3_CanoR_1 237 245 PF00244 0.365
LIG_14-3-3_CanoR_1 265 273 PF00244 0.424
LIG_14-3-3_CanoR_1 30 35 PF00244 0.244
LIG_14-3-3_CanoR_1 361 367 PF00244 0.435
LIG_14-3-3_CanoR_1 378 382 PF00244 0.385
LIG_14-3-3_CanoR_1 61 65 PF00244 0.337
LIG_14-3-3_CanoR_1 88 96 PF00244 0.407
LIG_APCC_ABBAyCdc20_2 406 412 PF00400 0.388
LIG_BIR_III_4 105 109 PF00653 0.153
LIG_BIR_III_4 401 405 PF00653 0.648
LIG_BRCT_BRCA1_1 21 25 PF00533 0.344
LIG_FHA_1 132 138 PF00498 0.283
LIG_FHA_1 173 179 PF00498 0.246
LIG_FHA_1 217 223 PF00498 0.312
LIG_FHA_1 321 327 PF00498 0.391
LIG_FHA_1 331 337 PF00498 0.413
LIG_FHA_1 358 364 PF00498 0.467
LIG_FHA_1 378 384 PF00498 0.523
LIG_FHA_1 386 392 PF00498 0.561
LIG_FHA_1 413 419 PF00498 0.407
LIG_FHA_2 15 21 PF00498 0.336
LIG_FHA_2 159 165 PF00498 0.408
LIG_FHA_2 167 173 PF00498 0.371
LIG_FHA_2 36 42 PF00498 0.502
LIG_FHA_2 64 70 PF00498 0.367
LIG_GBD_Chelix_1 296 304 PF00786 0.404
LIG_LIR_Gen_1 131 138 PF02991 0.384
LIG_LIR_Gen_1 164 172 PF02991 0.301
LIG_LIR_Gen_1 63 70 PF02991 0.362
LIG_LIR_Nem_3 131 136 PF02991 0.387
LIG_LIR_Nem_3 164 170 PF02991 0.334
LIG_LIR_Nem_3 254 260 PF02991 0.422
LIG_LIR_Nem_3 63 67 PF02991 0.308
LIG_MYND_3 304 308 PF01753 0.217
LIG_PCNA_yPIPBox_3 129 141 PF02747 0.254
LIG_SH2_GRB2like 95 98 PF00017 0.246
LIG_SH2_NCK_1 190 194 PF00017 0.182
LIG_SH2_STAP1 190 194 PF00017 0.182
LIG_SH2_STAT5 204 207 PF00017 0.371
LIG_SH2_STAT5 26 29 PF00017 0.431
LIG_SH2_STAT5 64 67 PF00017 0.382
LIG_SH2_STAT5 95 98 PF00017 0.305
LIG_SH3_3 9 15 PF00018 0.576
LIG_SUMO_SIM_anti_2 134 139 PF11976 0.422
LIG_SUMO_SIM_anti_2 333 339 PF11976 0.443
LIG_SUMO_SIM_par_1 380 389 PF11976 0.527
LIG_TRAF2_1 422 425 PF00917 0.421
LIG_TYR_ITIM 93 98 PF00017 0.304
LIG_UBA3_1 408 413 PF00899 0.637
LIG_WRC_WIRS_1 64 69 PF05994 0.153
MOD_CK1_1 166 172 PF00069 0.160
MOD_CK1_1 82 88 PF00069 0.421
MOD_CK2_1 14 20 PF00069 0.497
MOD_CK2_1 166 172 PF00069 0.407
MOD_CK2_1 68 74 PF00069 0.228
MOD_GlcNHglycan 112 115 PF01048 0.386
MOD_GlcNHglycan 121 124 PF01048 0.499
MOD_GlcNHglycan 3 6 PF01048 0.690
MOD_GlcNHglycan 373 376 PF01048 0.509
MOD_GSK3_1 20 27 PF00069 0.421
MOD_GSK3_1 277 284 PF00069 0.285
MOD_GSK3_1 320 327 PF00069 0.368
MOD_LATS_1 377 383 PF00433 0.504
MOD_N-GLC_1 117 122 PF02516 0.457
MOD_N-GLC_1 128 133 PF02516 0.356
MOD_N-GLC_1 172 177 PF02516 0.331
MOD_N-GLC_1 281 286 PF02516 0.340
MOD_N-GLC_1 96 101 PF02516 0.290
MOD_NEK2_1 238 243 PF00069 0.393
MOD_NEK2_1 330 335 PF00069 0.312
MOD_NEK2_1 35 40 PF00069 0.481
MOD_NEK2_1 60 65 PF00069 0.331
MOD_NEK2_1 68 73 PF00069 0.326
MOD_NEK2_1 96 101 PF00069 0.309
MOD_NEK2_2 128 133 PF00069 0.366
MOD_NEK2_2 274 279 PF00069 0.421
MOD_PIKK_1 213 219 PF00454 0.536
MOD_PK_1 30 36 PF00069 0.532
MOD_PKA_2 223 229 PF00069 0.526
MOD_PKA_2 377 383 PF00069 0.407
MOD_PKA_2 60 66 PF00069 0.158
MOD_Plk_1 128 134 PF00069 0.359
MOD_Plk_1 143 149 PF00069 0.322
MOD_Plk_1 158 164 PF00069 0.288
MOD_Plk_1 246 252 PF00069 0.316
MOD_Plk_2-3 303 309 PF00069 0.304
MOD_Plk_4 143 149 PF00069 0.326
MOD_Plk_4 240 246 PF00069 0.471
MOD_Plk_4 60 66 PF00069 0.369
MOD_Plk_4 82 88 PF00069 0.458
MOD_ProDKin_1 117 123 PF00069 0.458
MOD_ProDKin_1 395 401 PF00069 0.342
MOD_SUMO_rev_2 308 318 PF00179 0.371
TRG_DiLeu_BaLyEn_6 352 357 PF01217 0.261
TRG_ENDOCYTIC_2 64 67 PF00928 0.302
TRG_ENDOCYTIC_2 95 98 PF00928 0.304
TRG_ER_diLys_1 437 442 PF00400 0.582
TRG_NES_CRM1_1 303 314 PF08389 0.344
TRG_NLS_MonoExtC_3 27 32 PF00514 0.527
TRG_NLS_MonoExtC_3 435 440 PF00514 0.508
TRG_NLS_MonoExtN_4 28 33 PF00514 0.397
TRG_Pf-PMV_PEXEL_1 265 269 PF00026 0.297
TRG_Pf-PMV_PEXEL_1 355 359 PF00026 0.462

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N0P4N0 Leptomonas seymouri 25% 100%
A0A0N1HUH0 Leptomonas seymouri 29% 94%
A0A0N1I317 Leptomonas seymouri 26% 100%
A0A0N1PD72 Leptomonas seymouri 70% 99%
A0A0S4IT30 Bodo saltans 25% 66%
A0A0S4JGH2 Bodo saltans 26% 100%
A0A0S4JL85 Bodo saltans 46% 100%
A0A0S4JPV3 Bodo saltans 29% 92%
A0A1X0NTY3 Trypanosomatidae 28% 98%
A0A1X0P364 Trypanosomatidae 50% 100%
A0A3Q8IDE6 Leishmania donovani 28% 100%
A0A3R7L7Y9 Trypanosoma rangeli 28% 99%
A0A3R7P015 Trypanosoma rangeli 51% 93%
A0A3S5H5G2 Leishmania donovani 87% 100%
A0A3S7WZL6 Leishmania donovani 28% 100%
A4HEQ6 Leishmania braziliensis 29% 100%
A4HFQ6 Leishmania braziliensis 27% 100%
A4HHW0 Leishmania braziliensis 26% 100%
A4HSD0 Leishmania infantum 87% 100%
A4I1Y5 Leishmania infantum 28% 100%
A4I2T1 Leishmania infantum 28% 100%
C9ZPX6 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 50% 100%
C9ZS33 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 25% 99%
E9ADA9 Leishmania major 28% 100%
E9AKB9 Leishmania mexicana (strain MHOM/GT/2001/U1103) 86% 100%
E9AY32 Leishmania mexicana (strain MHOM/GT/2001/U1103) 29% 93%
E9AZ34 Leishmania mexicana (strain MHOM/GT/2001/U1103) 28% 100%
P10775 Sus scrofa 26% 97%
Q0VAA2 Homo sapiens 24% 91%
Q4Q9E1 Leishmania major 28% 100%
Q4QBG0 Leishmania major 24% 100%
Q4QJI8 Leishmania major 88% 100%
Q8IZ02 Homo sapiens 22% 95%
Q9LE82 Arabidopsis thaliana 26% 83%
Q9M651 Arabidopsis thaliana 26% 81%
V5BC66 Trypanosoma cruzi 29% 67%
V5BJF0 Trypanosoma cruzi 52% 89%
V5BPZ7 Trypanosoma cruzi 29% 98%
V5DHF2 Trypanosoma cruzi 24% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS